1. Beyer, J.: Angiotensinogensynthese der isoliert perfundierten Rattenleber und ihre Veränderung bei experimenteller Leberschädigung. Inaugural-Dissertation, Würzburg, 1975
2. Brown, J.J., Brown, W.C.B., Fraser, R., Lever, A.F., Morton, J.J., Robertson, J.I.S., Rosei, E.A., Trust, P.M.: The effects of angiotensin II-antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration. Prog. Biochem. Pharmacol.12, 230 (1976)
3. Case, D.B., Wallace, J.M., Keim, H.J., Sealey, J.E., Laragh, J.H.: Usefulnes and limitations of saralasin, a partial competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patients. Amer. J. Med.60, 825 (1976)
4. Figueroa, J.E., Benett, D.J., DeCamp, P.T., Batson, H.M.: Experience with renal vein renin ratios in the identification of a pressor kidney. South. Med. J.68, (No. 10), 1200 (1975)
5. Genest, J., Nowaczynsky, W., Koiw, E., Sandor, T., Biron, P.: Adrenocortical function in essentiell hypertension. In: Essentiell Hypertension. An International Symposion. ed. by. K.D. Bock and P.T. Cottier, Springer Verlag, Berlin (1960)